RAD51 foci in patient-derived ovarian cancer organoids are associated with response to carboplatin and olaparib

被引：0
|
作者：
Compadre, Amanda [1 ]
van Biljon, Lillian [1 ]
Fashemi, Bisiayo [1 ]
Graham, Olivia [1 ]
Rodriguez, Jeimmy [1 ]
Lomonosova, Elena [1 ]
Blachut, Barbara [1 ]
Kuroki, Lindsay [1 ]
McCourt, Carolyn [1 ]
Hagemann, Andrea [1 ]
Thaker, Premal [1 ]
Massad, L. [1 ]
Powell, Matthew [1 ]
Mutch, David [1 ]
Fuh, Katherine [1 ,2 ]
Khabele, Dineo [1 ]
Mullen, Mary [1 ]
机构：
[1] Washington Univ St Louis, St Louis, MO USA
[2] Univ Calif San Francisco, San Francisco, CA USA
来源：
GYNECOLOGIC ONCOLOGY | 2023年 / 176卷
关键词：
D O I：
10.1016/j.ygyno.2023.06.406
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2288
引用
收藏
页码：S308 / S309
页数：2
相关论文
共 50 条
  • [1] Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts
    Guffanti, F.
    Alvisi, M. F.
    Anastasia, A.
    Ricci, F.
    Chiappa, M.
    Llop-Guevara, A.
    Serra, V
    Fruscio, R.
    Degasperi, A.
    Nik-Zainal, S.
    Bani, M. R.
    Lupia, M.
    Giavazzi, R.
    Rulli, E.
    Damia, G.
    BRITISH JOURNAL OF CANCER, 2022, 126 (01) : 120 - 128
  • [2] Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts
    F. Guffanti
    M F Alvisi
    A. Anastasia
    F. Ricci
    M. Chiappa
    A. Llop-Guevara
    V. Serra
    R. Fruscio
    A. Degasperi
    S. Nik-Zainal
    M R Bani
    M. Lupia
    R. Giavazzi
    E. Rulli
    G. Damia
    British Journal of Cancer, 2022, 126 : 120 - 128
  • [3] Correction to: Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts
    F. Guffanti
    M F Alvisi
    A. Anastasia
    F. Ricci
    M. Chiappa
    A. Llop-Guevara
    V. Serra
    R. Fruscio
    A. Degasperi
    S. Nik-Zainal
    M R Bani
    M. Lupia
    R. Giavazzi
    E. Rulli
    G. Damia
    British Journal of Cancer, 2023, 128 : 1405 - 1405
  • [4] Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts (vol 126, pg 122, 2022 )
    Guffanti, F.
    Alvisi, M. F.
    Anastasia, A.
    Ricci, F.
    Chiappa, M.
    Llop-Guevara, A.
    Serra, V.
    Fruscio, R.
    Degasperi, A.
    Nik-Zainal, S.
    Bani, M. R.
    Lupia, M.
    Giavazzi, R.
    Rulli, E.
    Damia, G.
    BRITISH JOURNAL OF CANCER, 2023, 128 (07) : 1405 - 1405
  • [5] RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer
    Compadre, Amanda J.
    van Biljon, Lillian N.
    Valentine, Mark C.
    Llop-Guevara, Alba
    Graham, Emily
    Fashemi, Bisiayo
    Herencia-Ropero, Andrea
    Kotnik, Emilee N.
    Cooper, Isaac
    Harrington, Shariska P.
    Kuroki, Lindsay M.
    McCourt, Carolyn K.
    Hagemann, Andrea R.
    Thaker, Premal H.
    Mutch, David G.
    Powell, Matthew A.
    Sun, Lulu
    Mosammaparast, Nima
    Serra, Violeta
    Zhao, Peinan
    Lomonosova, Elena
    Khabele, Dineo
    Mullen, Mary M.
    CLINICAL CANCER RESEARCH, 2023, 29 (13) : 2466 - 2479
  • [6] RAD51 recruitment but not replication fork stability associates with PARP inhibitor response in ovarian cancer patient-derived xenograft models
    Talens, Francien
    Teixeira, Vivian Oliviera Nunes
    Kok, Yannick P.
    Chen, Mengting
    Rosenberg, Efraim H.
    Debipersad, Rashmie
    Duiker, Evelien W.
    van den Tempel, Nathalie
    Janatova, Marketa
    Zemankova, Petra
    Nederlof, Petra M.
    Wisman, G. Bea A.
    Kleibl, Zdenek
    de Jong, Steven
    van Vugt, Marcel A. T. M.
    NAR CANCER, 2024, 6 (04):
  • [7] Utilizing Patient-Derived Epithelial Ovarian Cancer Tumor Organoids to Predict Carboplatin Resistance
    Gorski, Justin W.
    Zhang, Zhuwei
    McCorkle, J. Robert
    DeJohn, Jodi M.
    Wang, Chi
    Miller, Rachel W.
    Gallion, Holly H.
    Dietrich, Charles S.
    Ueland, Frederick R.
    Kolesar, Jill M.
    BIOMEDICINES, 2021, 9 (08)
  • [8] BRCA1 foci test as a predictive biomarker of olaparib response in ovarian cancer patient-derived xenograft models
    Guffanti, Federica
    Mengoli, Ilaria
    Alvisi, Maria Francesca
    Dellavedova, Giulia
    Giavazzi, Raffaella
    Fruscio, Robert
    Rulli, Eliana
    Damia, Giovanna
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [9] Automated Scoring to Assess RAD51-Mediated Homologous Recombination in Ovarian Patient-Derived Tumor Organoids
    Thorel, Lucie
    Elie, Nicolas
    Morice, Pierre-Marie
    Weiswald, Louis-Bastien
    Florent, Romane
    Perreard, Marion
    Giffard, Florence
    Ricou, Agathe
    Leman, Raphael
    Babin, Guillaume
    Lebrun, Jean-Francois
    Martin, Sandrine
    Briand, Melanie
    Lambert, Bernard
    Joly, Florence
    Blanc-Fournier, Cecile
    Vaur, Dominique
    Dolivet, Enora
    Plancoulaine, Benoit
    Poulain, Laurent
    LABORATORY INVESTIGATION, 2025, 105 (04)
  • [10] Nuclear Rad51 foci induced by DNA damage are distinct from Rad51 foci associated with B cell activation and recombination
    Li, MJ
    Maizels, N
    EXPERIMENTAL CELL RESEARCH, 1997, 237 (01) : 93 - 100
12345